MY194244A - Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including Nsclc - Google Patents
Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including NsclcInfo
- Publication number
- MY194244A MY194244A MYPI2019007417A MYPI2019007417A MY194244A MY 194244 A MY194244 A MY 194244A MY PI2019007417 A MYPI2019007417 A MY PI2019007417A MY PI2019007417 A MYPI2019007417 A MY PI2019007417A MY 194244 A MY194244 A MY 194244A
- Authority
- MY
- Malaysia
- Prior art keywords
- present
- tumor
- relates
- lung cancer
- against several
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to more than 70 novel peptide sequences and their variants derived from HLA class I and HLA class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI2019007417A MY194244A (en) | 2015-11-24 | 2015-11-24 | Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including Nsclc |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI2019007417A MY194244A (en) | 2015-11-24 | 2015-11-24 | Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including Nsclc |
Publications (1)
Publication Number | Publication Date |
---|---|
MY194244A true MY194244A (en) | 2022-11-24 |
Family
ID=87569353
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2019007417A MY194244A (en) | 2015-11-24 | 2015-11-24 | Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including Nsclc |
Country Status (1)
Country | Link |
---|---|
MY (1) | MY194244A (en) |
-
2015
- 2015-11-24 MY MYPI2019007417A patent/MY194244A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12015502638A1 (en) | Novel immunotherapy against several tumors, such as lung cancer, including nsclc | |
PH12021551208A1 (en) | Novel immunotherapy against several tumors, such as lung cancer, including nsclc | |
PH12019502194A1 (en) | Novel immunotherapy against several tumors including gastrointestinal and gastric cancer | |
MA39907A (en) | Novel immunotherapy against several tumors of the blood, such as acute myeloid leukemia (aml) | |
EP3708185A3 (en) | Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (cll) | |
MX2016005866A (en) | Personalized immunotherapy against several neuronal and brain tumors. | |
MX338294B (en) | Novel immunotherapy against several tumors including neuronal and brain tumors. | |
MX2010001086A (en) | Novel immunotherapy against neuronal and brain tumors. | |
MX2019013163A (en) | Novel immunotherapy against several tumors of the blood, such as acute myeloid leukemia (aml). | |
MY194241A (en) | Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including NSCLC | |
MY193910A (en) | Novel immunotherapy against several tumors, such as lung cancer, including nsclc | |
MY194653A (en) | Novel immunotherapy against several tumors, such as lung cancer, including nsclc | |
MY194244A (en) | Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including Nsclc | |
EA202090822A2 (en) | A NEW METHOD FOR IMMUNOTHERAPY OF SEVERAL TUMORS OF TUMORS SUCH AS LUNG CANCER, INCLUDING NSCLC | |
MX2019013161A (en) | Personalized immunotherapy against several neuronal and brain tumors. |